Paul L Crispen, M.D.
(352) 265-8240
Current patients: Succinate dehydrogenase deficient renal cell carcinoma: A case report. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors. Predicting long-term postsurgical pain by examining the evolution of acute pain. Patient and Procedural Determinants of Postoperative Pain Trajectories. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Hyal2 Expression in Tumor-Associated Myeloid Cells Mediates Cancer-Related Inflammation in Bladder Cancer. Association between nuclear grade of renal cell carcinoma and the aorta-lesion-attenuation-difference. Mechanisms of immune evasion in bladder cancer. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors. Evaluation of Intraoperative Versus Postoperative Adjuvant Mitomycin C with Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract. Lymph Node Dissection for Small Renal Masses. Delayed Intervention of Small Renal Masses on Active Surveillance. Low Grade Lymphoma Mimicking Metastatic Urothelial Carcinoma: When Do We Need Further Histologic Staging? Stone Size Limits The Use Of Hounsfield Units For Prediction Of Calcium Oxalate Stone Composition. Should we perform prostatectomy in the face of metastatic prostate cancer? New primary malignancy masquerading as metastatic prostate adenocarcinoma. Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma. How Best to Predict Tumor Control and Renal Function after Treatment of Renal Masses. Displacement of the Spleen Mimicking Renal Cell Cancer Recurrence Post-Nephrectomy: A Case Report. Metabolic bone disease following urinary diversion in adults. High Rates Of Advanced Disease, Complications, And Decline Of Renal Function After Radical Nephroureterectomy. Small renal masses: the effect of illness uncertainty during active surveillance. Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. Patterns of care for renal surgery: Underutilization of nephron-sparing procedures. Editorial comment. Association of clinical and radiographic features with perinephric "sticky" fat. Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma. NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study. Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma. Bilateral ovarian steroid cell tumours and massive macronodular adrenocortical disease in a patient with hereditary leiomyomatosis and renal cell cancer syndrome. Association of tumor size, location, R.E.N.A.L., PADUA and centrality index score with perioperative outcomes and postoperative renal function. Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma. Treatment of patients with small renal masses: a survey of the American Urological Association. Temporal relationship between positive margin rate after laparoscopic radical prostatectomy and surgical training. Second prize: In-vivo physiological impact of alpha blockade on the porcine ureter with distal ureteral obstruction. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Hand-assisted laparoscopic partial nephrectomy without formal collecting system closure: perioperative outcomes in 104 consecutive patients. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? Unclassified renal cell carcinoma: impact on survival following nephrectomy. Tissue microarrays: one size does not fit all. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. Radical prostatectomy for prostate cancer after ileal pouch-anal anastomosis offers oncologic control and sustains quality of life. Penile intraepithelial neoplasia and other premalignant lesions of the penis. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis. Radiation therapy after radical prostatectomy: impact on metastasis and survival. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Lymphadenectomy in renal cell carcinoma: When and to what extent? Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases. Editorial comment. Editorial comment on: Renal angiomyolipoma: long-term results following selective arterial embolization. Do percutaneous renal tumor biopsies at initial presentation affect treatment strategies? Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis. What is the clinical significance of ipsilateral renal lesions during nephron-sparing surgery? Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens. Predicting growth of solid renal masses under active surveillance. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Pathologic concordance of sporadic synchronous bilateral renal masses. Outcomes following partial nephrectomy by tumor size. Multifocal renal cell carcinoma: clinicopathologic features and outcomes for tumors =4 cm. Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer. Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy. Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation. Functional and oncological outcomes after orthotopic neobladder reconstruction in women. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Delayed intervention of sporadic renal masses undergoing active surveillance. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. The natural history of untreated renal masses. Renal Cell Carcinoma: Can Some Be Observed? Immediate postoperative complications of combined penetrating rectal and bladder injuries. Enhancing renal masses with zero net growth during active surveillance. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy. Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis.
Log in to MyUFHealth
Primary tabs
Publications
Urology case reports
2022
European urology
2022
Abdominal radiology (New York)
2021
European journal of pain (London, England)
2021
Anesthesiology
2021
The Lancet. Oncology
2021
Cancer research
2021
Abdominal radiology (New York)
2021
Cancer immunology, immunotherapy : CII
2020
Urology
2019
Bladder cancer (Amsterdam, Netherlands)
2018
The Urologic clinics of North America
2017
Journal of kidney cancer and VHL
2017
Case reports in oncological medicine
2016
Urology
2015
The Journal of urology
2015
Case reports in oncological medicine
2015
Clinical cancer research : an official journal of the American Association for Cancer Research
2015
The Journal of urology
2015
Journal of kidney cancer and VHL
2015
Current opinion in urology
2014
Urologic Oncology
2014
Nature reviews. Urology
2013
BJU international
2013
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
2013
Urology
2013
Journal of endourology
2013
Current urology reports
2012
The Canadian journal of urology
2012
The Journal of urology
2012
Pathology
2012
The Journal of urology
2012
Cancer
2012
The Journal of urology
2011
Urology
2011
Journal of endourology
2011
European urology
2011
Journal of endourology
2011
BJU international
2011
Urology
2010
Diagnostic pathology
2010
The Journal of urology
2010
Journal of the American College of Surgeons
2010
The Urologic clinics of North America
2010
The Journal of urology
2010
Cancer
2010
The Journal of urology
2010
The Journal of urology
2009
Urology
2009
The Journal of urology
2009
Cancer
2009
Kidney Cancer Journal
2009
Clinical cancer research : an official journal of the American Association for Cancer Research
2009
Urology
2009
European urology
2009
European urology
2009
Cell death and differentiation
2008
Nature clinical practice. Urology
2008
Clinical cancer research : an official journal of the American Association for Cancer Research
2008
European urology
2008
Clinical cancer research : an official journal of the American Association for Cancer Research
2008
The Journal of urology
2008
Urology
2008
Urologic oncology
2008
Cancer
2008
Urology
2008
The Journal of urology
2008
Advances in urology
2008
Cancer
2008
Journal of endourology
2008
Urology
2008
BJU international
2008
The Prostate
2008
Cancer
2008
The Prostate
2007
The Journal of urology
2007
BJU international
2007
2007
The Journal of trauma
2007
The Journal of urology
2007
The Journal of urology
2006
Carcinogenesis
2006
BJU international
2005
Oncogene
2005Active Research Studies